Author

A. C. Resnick

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 4

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 4 Approach:experimental assay· 3 Assay:bulk RNA-seq· 2 Research Focus:differential expression· 2 Research Focus:drug response / drug discovery· 2 Assay:whole-genome sequencing· 2 Research Focus:cell type annotation· 1 Assay:clinical cohort / trial· 1

Frequent Co-Authors

P. B. Storm· 4 shared A. J. Waanders· 3 shared J. L. Rokita· 3 shared H. Ijaz· 2 shared K. A. Cole· 2 shared K. S. Gaonkar· 2 shared M. Li· 2 shared S. J. Diskin· 2 shared

Activity by Year

2019-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 44 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

4 shared papersCancer Biology

P. B. Storm

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

ALT in Pediatric High-Grade Gliomas Can Occur without ATRX Mutation and is Enriched in Patients with Pathogenic Germline MMR Variants

J. L. Stundon, H. Ijaz, K. S. Gaonkar, R. S. Kaufman, R. Jin, A. Karras, Z. Vaksman, J. Kim, R. J. Corbett, M. R. Lueder, D. P. Miller, Y. Guo, M. Santi, M. Li, G. Lopez, , K. A. Cole

This paper identifies ALT in pediatric high-grade gliomas without ATRX mutations and links it to germline MMR variants.

bioRxiv · Aug 5, 2022 · PreprintCancer Biology

Development of GPC2-directed chimeric antigen receptors using mRNA for pediatric brain tumors

J. B. Foster, C. Griffin, J. L. Rokita, A. Stern, C. Brimley, K. Rathi, M. V. Lane, S. N. Buongervino, T. Smith, P. J. Madsen, D. Martinez, R. Wechsler-Reya, K. Kariko, P. B. Storm, D. M. Barrett, , K. R. Bosse

This study develops mRNA chimeric antigen receptor T cells targeting GPC2 on pediatric brain tumors, showing significant tumor regression and prolonged survival without toxicity.

bioRxiv · Jul 6, 2021Cancer Biology

Novel BRAF gene fusions in pediatric histiocytic neoplasms define distinct therapeutic responsiveness to RAF paradox breakers

P. Jain, L. F. Surrey, J. Straka, P. Russo, R. Womer, M. Li, P. B. Storm, A. J. Waanders, M. D. Hogarty, A. C. Resnick, J. Picarsic

The paper identifies two novel BRAF gene fusions in pediatric histiocytic neoplasms and shows they respond differently to RAF inhibitor therapies due to distinct dimerization mechanisms.

bioRxiv · Apr 13, 2020Cancer Biology

Pediatric High Grade Glioma Resources From the Children’s Brain Tumor Tissue Consortium (CBTTC) and Pediatric Brain Tumor Atlas (PBTA)

H. Ijaz, M. P. Koptyra, K. S. Gaonkar, J. L. Rokita, V. P. Baubet, L. Tauhid, Y. Zhu, M. A. Brown, G. Lopez Garcia, B. Zhang, S. J. Diskin, Z. Vaksman, J. L. Mason, E. M. Appert, J. V. Lilly, , K. A. Cole

This paper describes a resource of pediatric high grade glioma (pHGG) data and biospecimens from the CBTTC and PBTA, including genomic, clinical, and imaging data, along with cell lines and tissue microarrays.

bioRxiv · May 31, 2019Cancer Biology